Our News section keeps you up to speed with the latest developments at Cytel.

Cytel acquires MTEK Sciences, further expanding its advanced Real World Analytics capabilities

November 5, 2019

Copenhagen, Denmark ISPOR Europe 2019 November 05 2019Cytel Inc. (“Cytel” or the “Company”), the leading provider of innovative analytical software and consulting services to the biopharmaceutical sector, and a portfolio company of New Mountain Capital, today announced that it has acquired MTEK Sciences (“MTEK”) to further expand its advanced real-world analytics (RWA) capabilities.

Read More

Cytel and Axio join forces to create an industry leader in analytical solutions for drug development

June 4, 2019

Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry, and Axio Research, a premier provider of biostatistics to pharmaceutical, biotechnology and medical device companies, today announced that they have joined forces to create the largest global biometrics organization focused on delivering advanced analytical solutions for the life sciences industry. The merged business will operate under the Cytel brand, with Axio continuing to provide its renowned data monitoring committee services for clinical trials, as “Axio, a Cytel company.”

Read More

Cytel Names Joshua Schultz as Chief Executive Officer

January 7, 2019

Cytel announced the appointment of Joshua Schultz as Chief Executive Officer (CEO) effective January 7th, 2019. He succeeds Joseph Avellone, who acted as Cytel’s interim CEO from March 2018 and will continue to serve on the company’s Board of Directors.

Mr. Schultz is an accomplished leader with a 20-year track record of success in life sciences and clinical research organizations. He joins Cytel from PAREXEL, where he most recently served as an Officer of the company and Senior Vice President for its Access business unit.  

Read More

Cytel Announces Launch of East 6.5

December 15, 2018

Cytel Inc., a global provider of advanced analytical solutions to the pharmaceutical, biotechnology, and medical device industries, today announced the launch of East® version 6.5, further enhancing the most trusted technology platform for designing, monitoring, and simulating adaptive trials.  Since 1995, East has empowered trial sponsors of all sizes to optimize study planning and monitoring efforts, accelerate timelines, and increase their probability of success in clinical development.

Read More

News: Announcing EnForeSys 2.0

July 17, 2018
Cytel Inc., a global provider of innovative analytical software and services to the biopharmaceutical industry, today announces the release of version 2.0 of its EnForeSys software. The upgraded version unveils expanded functionality that allows users improved interactivity and the ability to generate even more granular forecasts for resolving their feasibility challenges.
Read More

Cytel Announces Launch of East Lite

March 1, 2018
Cytel announces the launch of its East Lite app on iOS. Developed by the team responsible for East, East Lite features Normal, Binomial, and Survival endpoints and Survival and Non-inferiority designs with options for variance and test statistic.
The free tool is available for download on the App Store and gives biostatisticians the ability to conveniently and quickly create sample size and power calculations using their iPhone or iPad.
Read More

Cytel announced as a finalist in Informa CARE Awards

February 15, 2018
Cytel is confirmed as a finalist in Most Innovative Trial Design and Clinical Partnership of the Year categories at the Informa Clinical and Research Excellence Awards. The awards recognize innovation and excellence in the biopharma industry and Cytel is commended for its outsourcing partnership with Biogen and a innovative trial design created for sponsor   Nestlé Health Science. The winners will be announced in April at an awards ceremony in Boston.
Read More

Cytel announced as finalists at Informa CARE Awards

February 1, 2017
Cytel is confirmed as a finalist in Most Innovative Trial Design and Best Sponsor-focused Technological Development categories at the Informa Clinical and Research Excellence Awards. The awards recognize innovation and excellence in the biopharma industry and Cytel is recognized for developments on East 6.4 and a innovative trial design created for sponsor Tracon Pharmaceuticals. The winners will be announced in April.
Read More